giving us your opinion. It's like we said all along ... we still need more information on HCQ just like the other therapeutics. Certainly, we shouldn't be taking HCQ outside of a hospital setting like Trump claimed.

Where are you getting there are "no safety issues" and "clear benefit" when the study itself says to take their interpretation with caution? The study is a start, but far from your HCQ narrative.

Here is there conclusion:

"Findings of this observational study provide crucial data on experience with hydroxychloroquine therapy, providing necessary interim guidance for COVID-19 therapeutic practice. These findings do support the recent NIH guidelines (Antiviral Therapy, 2020), indicating a potential role for hydroxychloroquine in treatment of hospitalized COVID-19 patients without co-administration of azithromycin. However, our results should be interpreted with some caution and should not be applied to patients treated outside of hospital settings. Our results also require further confirmation in prospective, randomized controlled trials that rigorously evaluate the safety, and efficacy of hydroxychloroquine therapy for COVID-19 in hospitalized patients. Considered in the context of current studies on the use of hydroxychloroquine for COVID-19, our results suggest that hydroxychloroquine may have an important role to play in reducing COVID-19 mortality."